Mucopolysaccharidosis (MPS) Treatment Demand Assessment

Mucopolysaccharidosis (MPS) Treatment Market: Stem Cell Therapy Research to Prominently Uphold Growth Outlook: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

  • 44 Tables
  • 174 Figures
  • 220 pages
  • PDF PPT EXCEL
Mucopolysaccharidosis (MPS) Treatment Demand Assessment
  • SELECT LICENSE :

  • US$5,000
  • US$7,500
  • US$10,000

MPS Treatment – Focus Hinged at Clinical Trials and Drug Exclusivity

Clinical trials remain the focal point of MPS treatment drug manufacturers, in a bid to drive developments in new treatments, which range from gene therapy and enzyme replacement therapies, to pathophysiology. Drug exclusivity is one of the prime emphasized areas of research, encouraging the development of new biological products and drugs, for improving the provision of care.

Market Set to Grow 1.8X between 2019 and 2029

Clinical manifestations of MPS continue to derive a cascade of hypothetical research discoveries, which in turn have led realizations of pathways toward novel therapeutic targets. This will remain a key enabler of developments in adjunctive therapies for MPS in the foreseeable future.

Waves of Growth in Emerging Markets

Developed markets remain vital revenue pockets for stakeholders in the MPS treatment market, owing to a relatively aware population and economic vigour. However, emerging markets are considered to hold immense opportune potential, as governments in these economies increase expenditure on healthcare infrastructure & facilities. Comparatively denser proportion of demographic in emerging countries also add to greater occurrence possibility of rare genetic disorders, which in turn might create lucrative avenues for MPS treatment market players.

* This data is only a representation. Actual data may vary and will be available in report.

Waves of Growth in Emerging Markets
Waves of Growth in Emerging Markets
Waves of Growth in Emerging Markets
Waves of Growth in Emerging Markets
  • 2014
  • 2018
  • 2022
  • 2028
  • Arrow

MPS treatment market stakeholders have directed their focus toward leveraging analytics for effective correlations and calculative, personalized treatments. A palpable rise in incidences of MPS indications and notable growth in hospitalizations of associated chronic ailments, have provided an impetus to drug discovery & development activities. A prime focus area of research among players is breaking blood brain barrier via ERT treatment.

Enzyme replacement therapies are preferred treatment of choice for MPS-affected patients, accounting for bulk shares of the market.

Shares of stem cell therapies will continue to be marginal in the MPS treatment market

Hospitals continue to be the prime location for consultation and treatment among patients detected with MPS, accounting for over 90% shares.

Gains from specialty clinics will remain relatively significant compared to sluggish revenues from home infusion and medical research centres.

How Growth will Unfold

Gains from MPS II treatment are expected to account for leading market shares, as the prevalence of this MPS condition is relatively higher according to the International MPS Society. On the other hand, revenues from treatment of MPS I and MPS IVA are expected to grow at a relatively higher rate.

MPS II | MPS IVA | MPS I

* This data is only a representation. Actual data may vary and will be available in report.

Click Here To Know How The Growth Will Unfold

Read in-depth analysis on Mucopolysaccharidosis (MPS) Treatment Demand Assessment

Overview

Mucopolysaccharidosis Treatment Market: Global Industry Analysis 2014–2018 and Opportunity Assessment 2019–2029

A recent market study published by FMI “Mucopolysaccharidosis Treatment Market: Global Industry Analysis 2014–2018 and Opportunity Assessment 2019–2029” comprises a comprehensive assessment of the key market dynamics. After conducting thorough research on the historic as well as current growth parameters of the mucopolysaccharidosis treatment market, the growth prospects of the market are obtained with maximum precision.

Mucopolysaccharidosis Treatment Market Taxonomy

The global mucopolysaccharidosis treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.

By Treatment Type

  • Enzyme Replacement Therapies
  • Stem Cell Therapies
    • Bone Marrow Transplantation
    • Umbilical Cord Blood Transplantation

By Type of MPS

  • MPS I
  • MPS II
  • MPS IV A
  • MPS VI
  • MPS VII

By End User

  • Hospital
  • Specialty Clinics
  • Medical Research Centers
  • Home-infusion

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

What's Included

The mucopolysaccharidosis treatment market report commences with an executive summary of the key findings and key statistics of the mucopolysaccharidosis treatment market. It also includes the market value (US$ million) estimates of the leading segments of the mucopolysaccharidosis treatment market.

Readers can find detailed market taxonomy which highlights the inclusions and exclusions for the subject. The definition of mucopolysaccharidosis treatment market is included in this chapter, which helps in understanding the basic information about the concerned mucopolysaccharidosis treatment market, which helps the reader understand the scope of the mucopolysaccharidosis treatment market report.

This section explains about the key trends followed by the manufacturer and consumer in mucopolysaccharidosis treatment market. This section helps reader to understand the both supply-side and demand-side trend impacting the growth of mucopolysaccharidosis treatment market.

This chapter highlights the key success factors of the mucopolysaccharidosis treatment market, which include regulatory scenario, pipeline analysis, snapshot of developments for mucopolysaccharidosis Type 3, rare disease framework and designed designation for each treatment present.

This section explain the global market analysis and forecast for the mucopolysaccharidosis treatment market. It also highlights the incremental opportunity for the mucopolysaccharidosis treatment market along with the absolute dollar opportunity for every year between the forecast period of 2019-2029.

This chapter explains the key macro-economic factors that are expected to influence the growth of the mucopolysaccharidosis treatment market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the mucopolysaccharidosis treatment market. This chapter also highlights the key dynamics of the mucopolysaccharidosis treatment market, which include the drivers and restraints.

Based on the Treatment Type, the mucopolysaccharidosis treatment market is segmented into Enzyme Replacement Therapies and Stem Cell Therapies. Stem Cell Therapies is further segmented into Bone Marrow Transplantation and Umbilical Cord Blood Transplantation. In this chapter, readers can find a detailed analysis of the mucopolysaccharidosis treatment market by different Treatment Type and their expected growth over the forecast period.

Based on the Type of MPS, the mucopolysaccharidosis treatment market is segmented into MPS I, MPS II, MPS IV A, MPS VI and MPS VII. This section helps readers understand the prevalence of different Type of MPS in the mucopolysaccharidosis treatment market over the forecast period.

Based on end user, the mucopolysaccharidosis treatment market is segmented into Hospital, Specialty Clinics, Medical Research Centers and Home-infusion. In this chapter, readers can also understand the market attractive analysis based on the end user.

This chapter explains how the mucopolysaccharidosis treatment market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East & Africa (MEA).

This chapter includes a detailed analysis of the growth of the North America mucopolysaccharidosis treatment market along with a country-wise assessment, which includes the U.S. and Canada. Readers can also find the key takeaways of this region, and market growth based on treatment type, type of MPS, end user and country of mucopolysaccharidosis treatment in the North America region.

This chapter contains a snapshot of the Latin America mucopolysaccharidosis treatment market. It includes the growth prospects of the mucopolysaccharidosis treatment market in the leading LATAM countries such as Brazil, Mexico, Argentina and the rest of the Latin America region.

The important growth prospects of the mucopolysaccharidosis treatment market based on treatment type, type of MPS and end user in several European countries, such as the U.K., Germany, France, Italy, Spain, Russia and the rest of Western Europe, is included in this chapter.

This chapter highlights the growth of the mucopolysaccharidosis treatment market in Eastern Europe by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the mucopolysaccharidosis treatment market in East Asia.

India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia mucopolysaccharidosis treatment market in this chapter. Readers can find detailed information about the growth parameters of the South Asia mucopolysaccharidosis treatment market during the period 2019-2029.

Readers can find important factors that can significantly impact the growth of the mucopolysaccharidosis treatment market in Australia and New Zealand during the forecast period based on the market segmentation.

This chapter provides information about the growth of the mucopolysaccharidosis treatment market in the major countries of the MEA region, such as GCC Countries and South Africa, during the period 2019-2029.

This section explains the tier structure for global mucopolysaccharidosis treatment market which helps reader to understand the percent share of market cover by tier 1, tier 2, and tier 3 players in the mucopolysaccharidosis treatment market. This section also explains the company share analysis for mucopolysaccharidosis treatment market which helps readers to understand the market share taken by key players available in the market.

In this chapter, readers can find a comprehensive list of all the leading manufacturers in the mucopolysaccharidosis treatment market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the players featured in the mucopolysaccharidosis treatment market report are Sanofi S.A., Shire, BioMarin Pharmaceutical Inc., Ultragenyx Pharmaceutical Inc., Sarepta Therapeutics, Abeona Therapeutics, Inc., ArmaGen, Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva.

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

This chapter helps readers understand the research methodology followed to obtain various conclusions and important qualitative information & quantitative information about the mucopolysaccharidosis treatment market

How the research was conducted?

Primary Research

  • C - Level Executives
  • Marketing Directors
  • Sales Heads
  • Portfolio Managers
  • Purchasing Managers
  • Medical Officers
  • Device Development Heads
  • Strategy Advisors
  • R&D Managers
  • Product Manufacturers
  • Distributors
  • Component Suppliers / OEMs
  • Hospital Purchasing Departments
  • Physicians / Nursing Managers
  • Industry Experts
  • Current Market Dynamics and Challenges
  • Market Characteristics
  • Market Performance and Growth Quadrants
  • Competition Structure and Market Structure
  • Strategic Growth Initiatives
  • Product Adoption, Installed Base, Replacement Cycles, Refurbishment
  • Regulatory Landscape
  • Products in Pipeline and Clinical Development
  • Near-term and Long-term Market Growth Prospects
  • Market Segment Splits and Authenticity
  • Opinions on Market Projections and Validity of Assumptions

Secondary Research

  • Industry Magazines
  • Factiva
  • Company Press Releases
  • Annual Reports and Investor Presentations
  • Peer-reviewed Journals
  • Government Websites and Publications
  • Trade Websites
  • Clinical Trial Registries
  • Country-specific Regulatory Authorities
  • World Bank, WHO, IMF, OECD

Primary Interview Splits

Primary Research Interview Splits

Mucopolysaccharidosis Treatment Market Reports - Table of Contents

Figure 01: Pipeline Assessment For Mucopolysaccharidosis Treatment, By phase

Figure 02: Pipeline Assessment For Mucopolysaccharidosis Treatment, By Study Type

Figure 03: Global Mucopolysaccharidosis Treatment Market Value Analysis and Forecast, 2018–2029 (US$ Mn)

Figure 04: Global Mucopolysaccharidosis Treatment Market Absolute $ Opportunity (US$ Mn), 2014–2018

Figure 05: Global Mucopolysaccharidosis Treatment Market Absolute $ Opportunity (US$ Mn), 2019-2029

Figure 06: Global Mucopolysaccharidosis Treatment Market US$ Mn, by Treatment Type

Figure 07: Global Mucopolysaccharidosis Treatment Market Share%, by Treatment Type, 2019E

Figure 08: Global Mucopolysaccharidosis Treatment Market Share%, by Treatment Type, 2029F

Figure 09: Global Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 10: Global Mucopolysaccharidosis Treatment Market US$ Mn, by Type of MPS

Figure 11: Global Mucopolysaccharidosis Treatment Market Share%, by Type of MPS, 2019E

Figure 12: Global Mucopolysaccharidosis Treatment Market Share%, by Type of MPS, 2029F

Figure 13: Global Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type of MPS

Figure 14: Global Mucopolysaccharidosis Treatment Market US$ Mn, by End User

Figure 15: Global Mucopolysaccharidosis Treatment Market Share%, by End User, 2019E

Figure 16: Global Mucopolysaccharidosis Treatment Market Share%, by End User, 2029F

Figure 17: Global Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End User

Figure 18: Global Mucopolysaccharidosis Treatment Market US$ Mn, by Region

Figure 19: Global Mucopolysaccharidosis Treatment Market Share%, by Region, 2019E

Figure 20: Global Mucopolysaccharidosis Treatment Market Share%, by Region, 2029F

Figure 21: Global Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Region

Figure 22: North America Mucopolysaccharidosis Treatment Market Value Share (2018A), By Country

Figure 23: North America Mucopolysaccharidosis Treatment Market Value Share Comparison for 2018A and 2029F, By Treatment Type, Type of Mucopolysaccharidosis and End user

Figure 24: North America Mucopolysaccharidosis Treatment Market size (US$ Mn) Analysis, 2014–2018

Figure 25: North America Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 26: US Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 27: US Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 28: Canada Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 29: Canada Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 30: North America Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Enzyme Replacement Therapies

Figure 31: North America Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Enzyme Replacement Therapies

Figure 32: North America Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Stem Cell Therapies

Figure 33: North America Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Stem Cell Therapies

Figure 34: North America Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 35: North America Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End User

Figure 36: North America Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type Of MPS

Figure 37: North America Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Country

Figure 38: Latin America Mucopolysaccharidosis Treatment Market Value Share (2018A), By Country

Figure 39: Latin America Mucopolysaccharidosis Treatment Market Value Share Comparison for 2018A and 2029F, By Treatment Type, Type of Mucopolysaccharidosis and End user

Figure 40: Latin America Mucopolysaccharidosis Treatment Market size (US$ Mn) Analysis, 2014–2018

Figure 41: Latin America Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 42: Brazil Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 43: Brazil Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 44: Mexico Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 45: Mexico Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 46: Rest of Latin America Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 47: Rest of Latin America Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 48: Latin America Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Enzyme Replacement Therapies

Figure 49: Latin America Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Enzyme Replacement Therapies

Figure 50: Latin America Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Stem Cell Therapies

Figure 51: Latin America Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Stem Cell Therapies

Figure 52: Latin America Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 53: Latin America Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End User

Figure 54: Latin America Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type Of MPS

Figure 55: Latin America Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Country

Figure 56: Europe Mucopolysaccharidosis Treatment Market Value Share (2018A), By Country

Figure 57: Europe Mucopolysaccharidosis Treatment Market Value Share Comparison for 2018A and 2029F, By Treatment Type, Type of Mucopolysaccharidosis and End user

Figure 58: Europe Mucopolysaccharidosis Treatment Market size (US$ Mn) Analysis, 2014–2018

Figure 59: Europe Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 60: U.K. Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 61: U.K. Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 62: Germany Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 63: Germany Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 64: France Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 65: France Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 66: Italy Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 67: Italy Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 68: Spain Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 69: Spain Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 70: BENELUX Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 71: BENELUX Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 72: Russia Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 73: Russia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 74: Rest of Europe Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 75: Rest of Europe Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 76: Europe Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Enzyme Replacement Therapies

Figure 77: Europe Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Enzyme Replacement Therapies

Figure 78: Europe Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Stem Cell Therapies

Figure 79: Europe Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Stem Cell Therapies

Figure 80: Europe Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 81: Europe Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End User

Figure 82: Europe Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type Of MPS

Figure 83: Europe Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Country

Figure 84: South Asia Mucopolysaccharidosis Treatment Market Value Share (2018A), By Country

Figure 85: South Asia Mucopolysaccharidosis Treatment Market Value Share Comparison for 2018A and 2029F, By Treatment Type, Type of Mucopolysaccharidosis and End user

Figure 86: South Asia Mucopolysaccharidosis Treatment Market size (US$ Mn) Analysis, 2014–2018

Figure 87: South Asia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 88: India  Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 89: India  Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 90: Thailand Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 91: Thailand Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 92: Indonesia  Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 93: Indonesia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 94: Malaysia Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 95: Malaysia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 96: Rest of South Asia Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 97: Rest of South Asia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 98: South Asia Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Enzyme Replacement Therapies

Figure 99: South Asia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Enzyme Replacement Therapies

Figure 100: South Asia Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Stem Cell Therapies

Figure 101: South Asia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Stem Cell Therapies

Figure 102: South Asia Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 103: South Asia Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End User

Figure 104: South Asia Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type Of MPS

Figure 105: South Asia Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Country

Figure 106: East Asia Mucopolysaccharidosis Treatment Market Value Share (2018A), By Country

Figure 107: East Asia Mucopolysaccharidosis Treatment Market Value Share Comparison for 2018A and 2029F, By Treatment Type, Type of Mucopolysaccharidosis and End user

Figure 108: East Asia Mucopolysaccharidosis Treatment Market size (US$ Mn) Analysis, 2014–2018

Figure 109: East Asia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 110: China Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 111: China Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 112: Japan Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 113: Japan Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 114: South Korea Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 115: South Korea Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 116: East Asia Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Enzyme Replacement Therapies

Figure 117: East Asia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Enzyme Replacement Therapies

Figure 118: East Asia Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Stem Cell Therapies

Figure 119: East Asia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Stem Cell Therapies

Figure 120: East Asia Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 121: East Asia Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End User

Figure 122: East Asia Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type Of MPS

Figure 123: East Asia Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Country

Figure 124: Oceania Mucopolysaccharidosis Treatment Market Value Share (2018A), By Country

Figure 125: Oceania Mucopolysaccharidosis Treatment Market Value Share Comparison for 2018A and 2029F, By Treatment Type, Type of Mucopolysaccharidosis and End user

Figure 126: Oceania Mucopolysaccharidosis Treatment Market size (US$ Mn) Analysis, 2014–2018

Figure 127: Oceania Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 128: Australia Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 129: Australia Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 130: New Zealand Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 131: New Zealand Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 132: Oceania Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Enzyme Replacement Therapies

Figure 133: Oceania Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Enzyme Replacement Therapies

Figure 134: Oceania Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Stem Cell Therapies

Figure 135: Oceania Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Stem Cell Therapies

Figure 136: Oceania Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 137: Oceania Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End User

Figure 138: Oceania Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type Of MPS

Figure 139: Oceania Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Country

Figure 140: MEA Mucopolysaccharidosis Treatment Market Value Share (2018A), By Country

Figure 141: MEA Mucopolysaccharidosis Treatment Market Value Share Comparison for 2018A and 2029F, By Treatment Type, Type of Mucopolysaccharidosis and End user

Figure 142: MEA Mucopolysaccharidosis Treatment Market size (US$ Mn) Analysis, 2014–2018

Figure 143: MEA Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 144: South Africa Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 145: South Africa Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 146: GCC Countries Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 147: GCC Countries Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 148: Rest of MEA Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 149: Rest of MEA Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018

Figure 150: MEA Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Enzyme Replacement Therapies

Figure 151: MEA Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Enzyme Replacement Therapies

Figure 152: MEA Mucopolysaccharidosis Treatment Market Size (US$ Mn) Analysis, 2014–2018, by Stem Cell Therapies

Figure 153: MEA Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029, by Stem Cell Therapies

Figure 154: MEA Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 155: MEA Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End User

Figure 156: MEA Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type Of MPS

Figure 157: MEA Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Country

Figure 158: Mucopolysaccharidosis Treatment Market Value Proportion Analysis, By Key Countries, 2019E

Figure 159: Global Vs. Country, Y-O-Y Growth Comparison

Figure 160: India Mucopolysaccharidosis Treatment Market size (US$ Mn) Analysis, 2014–2018

Figure 161: India Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 162: India Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 163: India Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type Of MPS

Figure 164: India Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End User

Figure 165: Brazil Mucopolysaccharidosis Treatment Market size (US$ Mn) Analysis, 2014–2018

Figure 166: Brazil Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 167: Brazil Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 168: Brazil Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type Of MPS

Figure 169: Brazil Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End User

Figure 170: South Korea Mucopolysaccharidosis Treatment Market size (US$ Mn) Analysis, 2014–2018

Figure 171: South Korea Mucopolysaccharidosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 172: South Korea Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Treatment Type

Figure 173: South Korea Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By Type Of MPS

Figure 174: South Korea Mucopolysaccharidosis Treatment Market Attractiveness Analysis, By End 

Table 01: Comparison of orphan drug regulation across the US, Europe, Japan, Korea, Taiwan and China, 2017

Table 02:  Snapshot of Developments for Mucopolysaccharidosis Type 3

Table 03: Snapshot of Developments for Mucopolysaccharidosis Type 3 

Table 04: Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 05: Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of Mucopolysaccharidosis (MPS) 

Table 06: Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 07: Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Region

Table 08: North America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 09: North America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 10: North America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of MPS

Table 11: North America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 12: Latin America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 13: Latin America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 14: Latin America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of MPS

Table 15: Latin America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 16: Europe Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 17: Europe Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 18: Europe Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of MPS

Table 19: Europe Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 20: South Asia Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 21: South Asia Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 22: South Asia Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of MPS

Table 23: South Asia Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 24: East Asia Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 25: East Asia Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 26: East Asia Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of MPS

Table 27: East Asia Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 28: Oceania Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 29: Oceania Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 30: Oceania Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of MPS

Table 31: Oceania Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 32: MEA Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 33: MEA Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 34: MEA Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of MPS

Table 35: MEA Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 36: India Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 37: India Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of MPS

Table 38: India Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 39: Brazil Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 40: Brazil Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of MPS

Table 41: Brazil Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 42: South Korea Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Treatment Type

Table 43: South Korea Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By Type of MPS

Table 44: South Korea Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, By End User

To Learn More About our Comprehensive Perspective on Mucopolysaccharidosis (MPS) Treatment Demand Assessment, Contact Us

Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Client Partner - Global Business Development

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Methodology